LCLC-103HHomo sapiens (Human)Cancer cell line

Also known as: Large Cell Lung Cancer-103H, LCLC103H

🤖 AI SummaryBased on 6 publications

Quick Overview

Human non-small-cell lung cancer cell line with potential for drug sensitivity studies.

Detailed Summary

LCLC-103H is a human non-small-cell lung cancer cell line derived from a pleural effusion. It is characterized by large cell morphology and the presence of giant cells. This cell line has been used in studies related to cancer cell line diversity and genetic ancestry, highlighting its utility in understanding tumor heterogeneity and disparities in cancer research. LCLC-103H has been part of efforts to catalog genetic variations and neo-epitopes for immunotherapy research. Its properties make it a valuable model for investigating the molecular mechanisms of lung cancer and for developing targeted therapies.

Research Applications

Cancer researchDrug sensitivity studiesImmunotherapy researchGenetic variation analysis

Key Characteristics

Non-small-cell lung cancerLarge cell morphologyGiant cellsPleural effusion origin
Generated on 6/16/2025

Basic Information

Database IDCVCL_1375
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age61
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseLung large cell carcinoma
LineageLung
SubtypeLarge Cell Lung Carcinoma
OncoTree CodeLCLC

DepMap Information

Source TypeDSMZ
Source IDACH-000627_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Val216Leu (c.646G>T)Homozygous-Unknown, Unknown
MutationSimpleTERTc.1-124C>T (c.228C>T) (C228T)UnspecifiedIn promoterfrom parent cell line Hep-G2

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
11
D16S539
13
D18S51
19
D19S433
15
D21S11
29,31.2
D2S1338
16,19
D3S1358
16,17
D5S818
11,12
D7S820
8,11
D8S1179
12,14
FGA
22
Penta D
9
Penta E
16
TH01
6
TPOX
8
vWA
14,16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines.

Jaques G., Gropp C., Haeder M.

Differentiation 37:158-171(1988).

Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines.

Carney D.N., Vooijs G.P., Ramaekers F.C.S.

J. Cell Sci. 91:91-108(1988).

Novel antigens characteristic of neuroendocrine malignancies.";

Boerman O.C., Ramaekers F.C.S.

Cancer 67:619-633(1991).